Stay updated on Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed extensive details about a clinical study on DS107 for Atopic Dermatitis, including the study's objectives, methodology, and inclusion/exclusion criteria, while adding a new version number and a reference to Atopic Dermatitis.SummaryDifference23%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Orally Administered DS107 in Atopic Dermatitis Clinical Trial page.